Specialty Enzymes & Probiotics has released a clinical study highlighting the oral health benefits of Bactase Pet PB, a proprietary enzyme blend tailored for canine dental health.
Read More
The study was a 30-day randomized, double-blind, placebo-controlled trial where dogs receiving Bactase Pet PB twice daily demonstrated significant improvements compared to the placebo group. Results indicated a 61-67% reduction in plaque, gingivitis, and bad breath.
Research on companion animals is infrequently conducted due to limited funding and the high costs associated with veterinary trials. A scientist pointed out that researchers typically focus on projects funded by sponsors. There are also substantial ethical and regulatory challenges regarding informed consent and animal welfare.
As a result, the pet supplement industry often relies on in vitro studies or modifies human data for pet applications. Reshma Rathi, Vice President of Specialty Enzymes & Probiotics, noted, "Conducting a double-blind, placebo-controlled trial in dogs isn't just scientifically rigorous — it's expensive. Most companies don't do it."
The investment in this research aims to provide formulators with reliable confidence in the products they introduce to the market. Bactase Pet PB stands out as one of the few pet oral health ingredients supported by clinical trial data specifically in dogs, giving brands substantial scientific backing.